INFECTIOUS DISEASES SOCIETY OF AMERICA for INFECTIOUS DISEASES SOCIETY OF AMERICA
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 4th Quarter - Report (this page) | Jan 16, 2009 | $116,112 | Replaced |
| 4th Quarter - Report | Jan 20, 2010 | $115,820 | Replaced |
| 4th Quarter - Amendment | Jan 20, 2010 | $115,820 | Replaced |
| 4th Quarter - Amendment | Jun 22, 2010 | $115,820 | Yes |
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Infectious Diseases; drug and vaccine research and development; antimicrobial resistance; hospital-acquired infections; immunizations; pandemic influenza, public health security and biodefense; global infectious diseases; biomedical research, reauthorization of President's Emergency Plan for AIDS Relief (PEPFAR); Lyme disease and other infectious diseases issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROBERT J GUIDOS | Director, Public Policy & Government Relations |
| JULIE HANTMAN | Senior Program Officer for Public Health |
| PADMA NATARAJAN | Program Officer for Science and Research |
| R MICHAEL OCHS | Government Relations Associate |
| ANDREA WEDDLE | Executive Director, HIV Medicine Association |
Medicare/Medicaid MMM
Reimbursement for outpatient infusion therapy; Physician payment cuts; Medicaid and Medicare Reform, including Medicare Prescription Drug Coverage; Average Sales Price; and Competitive Acquistion Program
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROBERT J GUIDOS | Director, Public Policy & Government Relations |
| R MICHAEL OCHS | Government Relations Associate |
| JASON SCULL | Program Officer for Clinical Affairs |
| ANDREA WEDDLE | Executive Director, HIV Medicine Association |
Budget/Appropriations BUD
Funding support for the Department of Health and Human Services, Centers for Disease Control and Prevention, National Institutes of Health, Health Resources and Services Administration, Food and Drug Administration and global programs for various infectious diseases related issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROBERT J GUIDOS | Director, Public Policy & Government Relations |
| JULIE HANTMAN | Senior Program Officer for Public Health |
| PADMA NATARAJAN | Program Officer for Science and Research |
| R MICHAEL OCHS | Government Relations Associate |
| ANDREA WEDDLE | Executive Director, HIV Medicine Association |
Medical/Disease Research/Clinical Labs MED
Medical liability; Antimicrobial resistance research; infectious diseases product research and development
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROBERT J GUIDOS | Director, Public Policy & Government Relations |
| JULIE HANTMAN | Senior Program Officer for Public Health |
| PADMA NATARAJAN | Program Officer for Science and Research |
| R MICHAEL OCHS | Government Relations Associate |
Affiliated organisations
| Organisation | Location |
|---|---|
| HIV MEDICINE ASSOCIATION | Arlington, VA, US |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.